Cross-Site Scripting Vulnerability in SourceCodester Drug Recommendation System
CVE-2026-94033

5.1MEDIUM

Key Information:

Vendor

Sourcecodester
Status
Drug Recommendation System
Vendor
CVE Published:
20 September 2026

Badges

👾 Exploit Exists🟡 Public PoC

What is CVE-2026-94033?

The SourceCodester Drug Recommendation System version 1.0 has a critical security flaw in the User Management component. This vulnerability occurs in the file /drug_recommender/Admin/add_user, where improper handling of user-supplied input allows for cross-site scripting (XSS). Attackers can exploit this weakness by manipulating the parameters 'txtname', 'txtemail', and 'txtpassword', potentially executing arbitrary JavaScript in the user's browser. This issue can result in unauthorized actions and data exposure, making it essential for users of the affected product to take immediate precautions and apply any available fixes.

Affected Version(s)

Drug Recommendation System 1.0

Exploit Proof of Concept (PoC)

PoC code is written by security researchers to demonstrate the vulnerability can be exploited. PoC code is also a key component for weaponization which could lead to ransomware.

CVE-2026-94033 - Proof of Concept

References

https://vuldb.com/vuln/407961
vdb-entrytechnical-description
https://vuldb.com/vuln/407961/cti
signaturepermissions-required
https://vuldb.com/cve/CVE-2026-94033
third-party-advisory

CVSS V4

Score:
5.1
Severity:
MEDIUM
Confidentiality:
None
Integrity:
Low
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
Unknown

Timeline

  • 🟡

    Public PoC available

  • 👾

    Exploit known to exist

  • Vulnerability published

  • Vulnerability Reserved

Credit

anubhav106 (VulDB User)
.